Biophytis SA (ALBPS) EUR0.1

Sell:€0.11Buy:€0.11€0.00 (0.73%)

Prices delayed by at least 15 minutes
Sell:€0.11
Buy:€0.11
Change:€0.00 (0.73%)
Deal now
Prices delayed by at least 15 minutes
Sell:€0.11
Buy:€0.11
Change:€0.00 (0.73%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

Key people

Stanislas Veillet
Chairman of the Board, Chief Executive Officer
Nicolas Fellmann
Chief Financial Officer
Jean Mariani
Director
Claude Allary
Independent Director
Nadine Coulm
Independent Director
Click to see more

Key facts

  • Shares in issue
    7.34m
  • EPIC
    ALBPS
  • ISIN
    FR001400OLP5
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    €3.82m
  • Employees
    18
  • Exchange
    Euronext Paris
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.